Galderma

Settlement of cancer allegations against blockbuster drug

French pharmaceutical company Sanofi has reached a principal agreement in the US on around 4,000 of the cases in which its now withdrawn blockbuster heartburn d...

FOKUS Patient turns international

FOKUS Patient is arranging conferences over 3 days in October, and this year, the focus will be on international collaborations.

Conference on Alzheimer’s reveals several advances in the field

In Gothenburg, Sweden, researchers and pharmaceutical companies from all over the world gathered to discuss one specific issue – neurological diseases. Life Sci...

Sweden and Denmark – this is how they choose their strategies

Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.

Aurevia

The new ZEISS Celldiscoverer 7 has been launched

Adaptable automation for advanced workflows.

Event: Drug Development – Serendipity or Science

Drug development is a challenging journey, we will discuss questions you may not even consider asking. SDS and Medicon Village welcome you to an engaging afternoon.

New study: Post-Covid symptoms are common even after mild Covid-19

According to researchers at the University of Gothenburg, loss of smell and taste, shortness of breath and chest symptoms are the most common complaints after a...

From spin-off to phase II

”The people there will basically become your new colleagues” – Carina Schmidt, former CEO of Athera, about working with different contractors.

Valves with piezo technology

Efficient control and regulation of gases in medical technology

Marie Gårdmark: Do EMA and FDA talk to each other?

Of course they do! The collaboration started already in 2003, writes Marie Gårdmark in a column.

The route to vaccines for everyone: “We did not just sit around and wait”

The pandemic was in full swing, and no one knew when or even if a vaccine would come. At that point, the Swedish Minister of Social Affairs called with a propos...

Lucy Robertshaw: Are we in the perfect storm?

“Is there a perfect storm on the horizon again as elective surgeries were cancelled due to patients being admitted with Covid-19? We now have a long backlog of ...

Introduction of ZEISS Imaging Systems for Super-Resolution

Webinar recording about the ZEISS Lattice SIM technology.

Improved processes and more

Discover the full potential and benefits.

Reliably gripping and turning small parts

The extremely compact rotary gripper module EHMD is the ideal choice in many life science applications where small objects need to be gripped and turned in conf...

Samuel Lagercrantz: Immunotherapy against cancer is still in its early stages

For more than 100 years, researchers have tried to target the body’s own immune system to fight cancer cells. They have occasionally been laughed at and ridicul...

Jan Holmgren to receive award for the development of cholera vaccine

Researcher Jan Holmgren is being awarded for the development of the first effective drinkable cholera vaccine. The award is given by the International Vaccine I...

Göran Stiernstedt: “We are the world’s worst at continuity”

Failed investments in primary care, an unreasonable system with online doctors and a public failure at coordinating the healthcare IT system. Göran Stiernstedt ...

High-performance Slide Scanner for Fluorescence, Brightfield and Polarization

ZEISS Axioscan 7 combines high speed digitization and outstanding image quality.

Study: Our behaviour may have been guided by wishful thinking during the pandemic

A new study suggests that we systematically underestimate health risks if and when it suits us. This was especially true during the pandemic, as our risk assess...

Vaccinpartners på väg att bli rivaler

Franska Valneva och danska Bavarian Nordic, två partners som distribuerat och marknadsfört varandras produkter sedan 2020, kommer snart att bli rivaler inom vac...

Danska läkemedelsfonder investerar i talangfabrik

Novo Nordisk Foundation, Lundbeck Foundation och Leo Foundation investerar 123 miljoner danska kronor, motsvarande omkring 188 miljoner svenska kronor, i ett ny...